Global

Jul 20, 2016
Not yet, says Reflector. But to judge from the European Parliament's latest foray into the subject, there could be plenty of support for such an approach.
Jul 12, 2016
Pharmaceutical Executive
By
A look at how Europe’s new accelerated drug approval scheme can move existing review pathways to something better—and take a page from the FDA experience as well.
Jul 07, 2016
The long planned for transparency of industry payments to doctors, pharmacists, nurses and others has shone some dappled light on the UK industry, writes Leela Barham.
Jul 05, 2016
The UK's Brexit vote has unleashed turbulence in Europe — not least on its pharma sector. Reflector reports.
Jul 01, 2016
Leela Barham looks at the implications for the UK industry in the aftermath of last week's vote for Brexit.
Jun 09, 2016
Radicals who wield real power at the EMA have gone public with their thinking about the role of regulators in the economic aspects of medicines provision.
Jun 01, 2016
By
Eleanor Biggs looks at the biggest uncertainties facing the pharma industry if the UK were to leave the EU.
Jun 01, 2016
NHS England head Simon Stevens believes the UK's PPRS needs significantly updating.
May 24, 2016
Is a more "light-touch" appraisal process the key to getting the UK's NICE to do more with less? Leela Barham reports.
May 06, 2016
Pharmaceutical Executive
European pharma is bracing itself for EFPIA’s June deadline requiring the disclosure of transfer-of-value transactions make to HCPs.
native1_300x100
Kamagra ohne Rezept

посмотреть
lorem ipsum